CD56, CD57, HBME1, CK19, GALECTIN-3 AND P63 IMMUNOHISTOCHEMICAL STAINS IN DIFFERENTIATING DIAGNOSIS OF THYROID BENIGN/MALIGN LESIONS AND NIFTP

Creative Commons License

TAŞTEKİN E., Keskin E. U., CAN N., Canberk S., Mut A. N. U., Erdogan E. G., ...More

POLISH JOURNAL OF PATHOLOGY, vol.70, no.4, pp.286-294, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 70 Issue: 4
  • Publication Date: 2019
  • Doi Number: 10.5114/pjp.2019.93131
  • Journal Name: POLISH JOURNAL OF PATHOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.286-294
  • Keywords: thyroid lesions, differential diagnosis, CK19, Galectin-3, CD56, CD57, p63, HBME1, FOLLICULAR VARIANT, LEU-7 ANTIGEN, EXPRESSION, BENIGN, CARCINOMA, TUMORS, CYTOKERATIN-19, CD56/N-CAM, NEOPLASMS, MARKERS
  • Ankara University Affiliated: Yes

Abstract

Detection of thyroid carcinoma has been steadily increased in the past few decades. After the recognition of NIFTP, also gain importance to differentiate benign tumors (follicular adenoma) from follicular patterned variants of papillary thyroid carcinoma (invasive and infiltrative follicular variant papillary thyroid carcinoma), and low-risk lesions of thyroid (NIFTP).